Infections and Colonization With the Third Group of Enterobacteriaceae in the Intensive Care Unit

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

179 participants

Study Classification

OBSERVATIONAL

Study Start Date

2017-04-01

Study Completion Date

2019-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

There is a lack of data whether colonization and infection with Enterobacteriaceae of the third group (EB3) affect the outcomes for ICU patients. This study evaluated the effects of EB3 colonization and infection on ICU mortality, ICU length of stay (LOS) and broad-spectrum antibiotic exposure. We focused on the sub type Enterobacter regarding its a priori higher risk of resistance.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Prognostic Factors and Therapeutic Management of ESBL Enterobacteriaceae in the ICU

NCT05833282

Drug Resistance, Multiple, Bacterial

UNKNOWN

Intensive Care Unit Acquired Infections in Patients Colonized With Extended Spectrum Enterobacteriaceae

NCT04903886

Ventilator Associated Pneumonia Bacteremia Abdominal Infection +1 more

UNKNOWN

Clinical Trial to Reduce Antibiotic Resistance in European Intensive Cares

NCT00976638

Hospital Acquired Infections

COMPLETED NA

Gut Microbiota Association With ESBL-E Colonisation and Subsequent ESBL-E Infection

NCT04131569

Extended Spectrum Beta-Lactamase Producing Bacteria Infection Microbial Colonization Critical Illness

UNKNOWN

Understanding and Modeling Reservoirs, Vehicles and Transmission of ESBL-producing Enterobacteriaceae in the Community and Long Term Care Facilities

NCT03477084

Resistance Bacterial Enterobacteriaceae Infections

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Critically Ill Enterobacteriaceae Infections Antibiotic Resistant Infection

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

critically ill patients

critically ill patients admitted in one of the 5 ICUs of the university hospital of Nancy during the year 2016 with documented third group enterobacteriaceae infection and/or colonization with third group enterobacteriaceae

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* adults critically ill patients admitted to the the participating ICUs during the study period
* with colonization and/or infection with a third group enterobacteriacea
* and with a lenght of stay \> 24h